0001213900-24-044878.txt : 20240517 0001213900-24-044878.hdr.sgml : 20240517 20240517210023 ACCESSION NUMBER: 0001213900-24-044878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240515 FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shakil Ian CENTRAL INDEX KEY: 0001826129 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40890 FILM NUMBER: 24962164 MAIL ADDRESS: STREET 1: C/O AUGMEDIX, INC. STREET 2: 1161 MISSION STREET, SUITE LL CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Augmedix, Inc. CENTRAL INDEX KEY: 0001769804 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 833299164 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 SUTTER STREET, SUITE 1300 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 561-989-2208 MAIL ADDRESS: STREET 1: 111 SUTTER STREET, SUITE 1300 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: Malo Holdings Corp DATE OF NAME CHANGE: 20190305 4 1 ownership.xml OWNERSHIP DOCUMENT X0508 4 2024-05-15 0 0001769804 Augmedix, Inc. AUGX 0001826129 Shakil Ian C/O AUGMEDIX, INC. 111 SUTTER STREET, SUITE 1300 SAN FRANCISCO CA 94104 1 1 0 0 CHIEF STRATEGY OFFICER 1 Common Stock 2024-05-15 4 M 0 3750 A 6750 D Common Stock 2024-05-15 4 S 0 1387 1.19 D 5363 D Restricted Stock Units 2024-05-15 4 M 0 3750 0 D Common Stock 3750 56250 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Represents an original award of 60,000 RSUs to acquire shares of the Company's common stock. The RSU is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. One-sixteenth (1/16th) of the RSU will vest quarterly in equal increments over four (4) years commencing on 02/15/2024, with the first one-sixteenth (1/16th) vesting on 5/15/2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Todd Holvick, Attorney-in-Fact 2024-05-15